Analysts at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the stock.
Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.
Check Out Our Latest Report on STRM
Streamline Health Solutions Trading Down 1.5 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last released its quarterly earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The firm had revenue of $4.48 million for the quarter.
Streamline Health Solutions Company Profile
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
See Also
- Five stocks we like better than Streamline Health Solutions
- Pros And Cons Of Monthly Dividend Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 11/4 – 11/8
- Find and Profitably Trade Stocks at 52-Week Lows
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.